BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34762228)

  • 1. Association of immunological features with clinical manifestations in primary Sjogren's syndrome: a single-center cross-sectional study.
    Relangi HSK; Naidu GSRSNK; Sharma V; Kumar M; Dhir V; Sharma SK; Sharma A; Minz RW; Jain S
    Clin Exp Med; 2022 Nov; 22(4):613-620. PubMed ID: 34762228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).
    Ramos-Casals M; Brito-Zerón P; Solans R; Camps MT; Casanovas A; Sopeña B; Díaz-López B; Rascón FJ; Qanneta R; Fraile G; Pérez-Alvarez R; Callejas JL; Ripoll M; Pinilla B; Akasbi M; Fonseca E; Canora J; Nadal ME; de la Red G; Fernández-Regal I; Jiménez-Heredia I; Bosch JA; Ayala MD; Morera-Morales L; Maure B; Mera A; Ramentol M; Retamozo S; Kostov B; ;
    Rheumatology (Oxford); 2014 Feb; 53(2):321-31. PubMed ID: 24162151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
    La Rocca G; Ferro F; Bulleri A; Fulvio G; Fonzetti S; Donati V; Romei C; Mosca M; Baldini C
    Clin Exp Rheumatol; 2022 Dec; 40(12):2344-2349. PubMed ID: 36533977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for cardiovascular disease in primary Sjögren's syndrome (pSS): a 20-year follow-up study.
    Santos CS; Salgueiro RR; Morales CM; Castro CÁ; Álvarez ED
    Clin Rheumatol; 2023 Nov; 42(11):3021-3031. PubMed ID: 37402929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab.
    Meiners PM; Arends S; Brouwer E; Spijkervet FK; Vissink A; Bootsma H
    Ann Rheum Dis; 2012 Aug; 71(8):1297-302. PubMed ID: 22258489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of rheumatoid factor as an immunological and prognostic marker in PSS patients.
    Maślińska M; Mańczak M; Kwiatkowska B
    Clin Rheumatol; 2019 May; 38(5):1301-1307. PubMed ID: 30810912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren's Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors.
    Quartuccio L; Gandolfo S; Zabotti A; Zandonella Callegher S; Fabro C; De Vita S
    Front Immunol; 2019; 10():1527. PubMed ID: 31354708
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epidemiology of primary Sjörgren's syndrome].
    Westhoff G; Zink A
    Z Rheumatol; 2010 Feb; 69(1):41-9. PubMed ID: 20012976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).
    Brito-Zerón P; Acar-Denizli N; Ng WF; Zeher M; Rasmussen A; Mandl T; Seror R; Li X; Baldini C; Gottenberg JE; Danda D; Quartuccio L; Priori R; Hernandez-Molina G; Armagan B; Kruize AA; Kwok SK; Kvarnström M; Praprotnik S; Sène D; Bartoloni E; Solans R; Rischmueller M; Suzuki Y; Isenberg DA; Valim V; Wiland P; Nordmark G; Fraile G; Bootsma H; Nakamura T; Giacomelli R; Devauchelle-Pensec V; Knopf A; Bombardieri M; Trevisani VF; Hammenfors D; Pasoto SG; Retamozo S; Gheita TA; Atzeni F; Morel J; Vollenveider C; Horvath IF; Sivils KL; Olsson P; De Vita S; Sánchez-Guerrero J; Kilic L; Wahren-Herlenius M; Mariette X; Ramos-Casals M;
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):102-112. PubMed ID: 30156539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry.
    Dumusc A; Ng WF; James K; Griffiths B; Price E; Pease C; Emery P; Lanyon P; Jones A; Bombardieri M; Sutcliffe N; Pitzalis C; Gupta M; McLaren J; Cooper A; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Barone F; Fisher B; Rauz S; Richards A; Bowman S
    Swiss Med Wkly; 2018; 148():w14588. PubMed ID: 29442344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between ocular and extra-ocular assessment in primary Sjögren's syndrome.
    Da Cunha E; Mariette X; Desmoulins F; Bergé E; Nocturne G; Benmalek A; Haigh O; Seror R; Labetoulle M; Rousseau A
    Joint Bone Spine; 2022 Oct; 89(5):105426. PubMed ID: 35716880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.
    Acar-Denizli N; Horváth IF; Mandl T; Priori R; Vissink A; Hernandez-Molina G; Armagan B; Praprotnik S; Sebastian A; Bartoloni E; Rischmueller M; Pasoto SG; Nordmark G; Nakamura H; Fernandes Moça Trevisani V; Retamozo S; Carsons SE; Maure-Noia B; Sánchez-Berná I; López-Dupla M; Fonseca-Aizpuru E; Melchor Díaz S; Vázquez M; Díaz Cuiza PE; de Miguel Campo B; Ng WF; Rasmussen A; Dong X; Li X; Baldini C; Seror R; Gottenberg JE; Kruize AA; Sandhya P; Gandolfo S; Kwok SK; Kvarnstrom M; Solans R; Sene D; Suzuki Y; Isenberg DA; Valim V; Hofauer B; Giacomelli R; Devauchelle-Pensec V; Atzeni F; Gheita TA; Morel J; Izzo R; Kalyoncu U; Szántó A; Olsson P; Bootsma H; Ramos-Casals M; Kostov B; Brito-Zerón P;
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):85-94. PubMed ID: 33095152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline disease activity influences subsequent achievement of patient acceptable symptom state in Sjögren's syndrome.
    Park EH; Ha YJ; Kang EH; Song YW; Scofield RH; Lee YJ
    Rheumatology (Oxford); 2021 Jun; 60(6):2714-2724. PubMed ID: 33188390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren's syndrome.
    Maślińska M; Mańczak M; Kwiatkowska B; Ramsperger V; Shen L; Suresh L
    Rheumatol Int; 2021 Mar; 41(3):643-649. PubMed ID: 33496802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of systemic activity of pediatric primary Sjögren's syndrome by EULAR Sjögren's syndrome disease activity index (ESSDAI).
    Kobayashi I; Okura Y; Ueki M; Tozawa Y; Takezaki S; Yamada M; Ariga T
    Mod Rheumatol; 2019 Jan; 29(1):130-133. PubMed ID: 29529894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
    Seror R; Bootsma H; Saraux A; Bowman SJ; Theander E; Brun JG; Baron G; Le Guern V; Devauchelle-Pensec V; Ramos-Casals M; Valim V; Dörner T; Tzioufas A; Gottenberg JE; Solans Laqué R; Mandl T; Hachulla E; Sivils KL; Ng WF; Fauchais AL; Bombardieri S; Priori R; Bartoloni E; Goeb V; Praprotnik S; Sumida T; Nishiyama S; Caporali R; Kruize AA; Vollenweider C; Ravaud P; Meiners P; Brito-Zerón P; Vitali C; Mariette X;
    Ann Rheum Dis; 2016 Feb; 75(2):382-9. PubMed ID: 25480887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of clinical and immunological characteristics between primary Sjögren's syndrome patients with positive and negative anti-SSB antibody].
    Han YJ; Li CH; Chen XY; Zhao JX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1000-1006. PubMed ID: 38101780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary gland ultrasound is associated with the presence of autoantibodies in patients with Sjögren's syndrome: A Danish single-centre study.
    Schmidt NS; Voss A; Nilsson AC; Terslev L; Just SA; Lindegaard HM
    PLoS One; 2022; 17(12):e0265057. PubMed ID: 36508457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.